disease 1,609 words KG: ent-dise-01761651
Contents

LATE (Limbic-Predominant Age-Related TDP-43 Encephalopathy)

Disease Info
TDP-43 PathologyPhosphorylated, ubiquitinated, and truncated TDP-43 inclusions
Limbic PredominancePrimary involvement of amygdala, hippocampus, and entorhinal cortex
Age AssociationTypically onset after age 80
Clinical PhenotypeAmnestic syndrome resembling AD but with distinct progression
Age 70-79Approximately 5-10% prevalence
Age 80-89Approximately 15-20% prevalence
Age 90+Up to 25-30% prevalence in some cohorts
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Related Hypotheses (30)

Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
Glycosaminoglycan Template Disruption Approach
Score: 0.60
TREM2-Dependent Microglial Senescence Transition
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
CYP46A1 Overexpression Gene Therapy
Score: 0.92

Related Analyses (9)

Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)